![]() | |||||
lung cancer | |||||
新闻 | |||||
Phase II Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1–Pretreated ... ... tumor. Results: For the secondary refractory metastatic non–small cell lung cancer cohort (RECIST v1.1), the ORR was 14%, median progression-free ...
| |||||
Prolonged Undetectable MRD May Indicate Cure in NSCLC - Cancer Therapy Advisor ... lung cancer (NSCLC), according to researchers. They reported findings to support this conclusion in Clinical Cancer Research. The researchers ...
| |||||
Optellum, Volpara Health Sign Agreement for Lung and Breast Cancer Care Collaboration brings together lung and breast imaging expertise to advance AI-driven cancer detection and early intervention.
| |||||
Aptamer-Modified Mesoporous Silica Nanoparticle for Nitric Oxide-Enhanced Targeted ... Lung cancer ranks among the top causes of cancer-related deaths, with over 85% of cases identified as nonsmall cell ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
![]() |
发送反馈 |
No comments:
Post a Comment